Introduction
============

The initiation and maintenance of penile erection is caused by relaxation of the blood vessels in the cavernosal smooth muscle (CSM), which results in an increased blood flow into the trabecular spaces of the corpora cavernosa ([@B01]). The control of CSM tone is mainly mediated by the adrenergic, cholinergic, and nonadrenergic, noncholinergic (NANC) systems ([@B02]). Noradrenaline, released from sympathetic nerves, induces contraction of penile CSM while parasympathetic innervations mediate smooth muscle relaxation in the trabecular network and cavernosal arterial venous bed ([@B03]). Nitric oxide (NO) released from NANC nerve endings and from the vascular endothelium is considered the most important mediator of CSM relaxation ([@B04]). Release of endothelium-derived NO is regulated by several factors, including vasodilator substances such as adrenomedullin (AM), which has been demonstrated to play a role as a modulator of erectile function ([@B05]-[@B07]).

AM consists of a 52-amino acid peptide, initially isolated from human pheochromocytoma cells, that displays vasorelaxant and hypotensive actions ([@B08]). AM has a ring structure formed by a disulfide bond and an amidated carboxyl terminal, and belongs to a family of peptides that include amylin and calcitonin gene-related peptide (CGRP) ([@B08]). In the vasculature, the relaxant response induced by AM is mediated by the seven-transmembrane G protein-coupled calcitonin receptor-like receptor (CRLR), which coassembles with Subtypes 2 and 3 of the receptor activity-modifying protein (RAMP) family, thus forming a receptor-coreceptor system ([@B09],[@B10]). Although the vasodilator effect of AM in different blood vessels is well characterized ([@B10]), few reports have described the effect of AM in CSM relaxation. However, it has been reported that intracavernosal injections of AM increased cavernosal pressure and penile length in cats ([@B05]). This response was not mediated by CGRP receptors and did not involve NO generation or the opening of K^+^ channels ([@B05],[@B06]). In anesthetized rats, intracavernosal administration of AM resulted in increased cavernous pressure and penile erection, which was attenuated by inhibitors of the NO-cGMP pathway ([@B07]). The relaxation induced by AM in isolated rabbit CSM strips does not involve NO, vasodilator prostanoids, or the opening of K^+^ channels ([@B11]). Finally, AM is localized in human endothelial cells of cavernous vessels, where it may contribute to penile erection ([@B12]). These findings imply that AM is a modulator of CSM tone and suggest that AM might potentiate erectile function. Moreover, based on the above-mentioned observations, it is possible to conclude that the mechanism by which AM induces vasorelaxation or erection varies with species, vascular bed studied, and experimental procedure employed.

The AM system has been postulated to have a cardioprotective role in a wide range of diseases ([@B13]). Cardiovascular diseases are often associated with erectile dysfunction (ED) ([@B14]), and, in this case, increased levels of AM may play a compensatory role for ED. Isolated CSM is a useful model for the study of penile erectile responses and ED ([@B15],[@B16]). Thus, the study of physiological expression and function of AM receptors in CSM may provide valuable information on the contribution of AM to CSM tone. The effect of AM on cavernous pressure and penile erection has been previously evaluated in anesthetized rats using intracavernous pressure measurements ([@B07]). However, to the best of our knowledge, there are no reports describing the receptors involved in AM-induced relaxation of rat CSM or the detailed mechanisms underlying such a response. The aims of the present study were to attempt a functional characterization of the AM receptors in rat CSM and to investigate the mechanisms underlying AM-induced relaxation in this tissue. In addition, quantitative real-time polymerase chain reaction (qRT-PCR), Western immunoblotting, and immunohistochemical assays were performed to verify expression of AM, CRLR, and RAMP1, -2, and -3 in rat CSM.

Material and Methods
====================

Animals
-------

Male Wistar rats weighing 250-300 g (50-70 days of age) were housed under standard laboratory conditions with free access to food and water. The housing conditions and experimental protocols were approved by the Animal Ethics Committee of the Universidade de São Paulo, Campus of Ribeirão Preto, Brazil (Protocol \#10.1.1293.53.4). The animals were anesthetized with isoflurane \[2-chloro-2-(difluoromethoxy)-1,1,1-trifluoro-ethane\] and killed by aortic exsanguination. CSM was removed for functional assays, Western immunoblotting, qRT-PCR, and immunohistochemical experiments.

qRT-PCR
-------

Total cellular RNA was extracted using Trizol^¯^ Reagent (Invitrogen, USA), and RNA was reverse transcribed to single-stranded cDNA using a High Capacity Kit (Applied Biosystems, USA) according to the manufacturer\'s protocol. For quantitative analysis of the genes of interest \[pre-pro-AM (Rn 00562327_m1), CRLR (Rn 00562334_m1), RAMP1 (Rn 01427056_m1), RAMP2 (Rn 00824652_m1), and RAMP3 (Rn 00571815_m1)\], a commercially available TaqMan Assay-on-Demand System that consists of a kit of oligonucleotides and probes was used (Applied Biosystems). Reverse transcription was performed using 1 µg total RNA for each sample in 20 µL of the total reaction mixture. The cDNA obtained was diluted 1:10, and 4.5 µL was used for each 10 µL of the qRT-PCR mixture using the TaqMan Master Mix (Applied Biosystems). Reactions were carried out in duplicate and analyzed with 7500 Sequence Detection System apparatus (Applied Biosystems). Data were analyzed using the ABI-7500 SDS software (Applied Biosystems). Total RNA absorbed was normalized on the basis of the Ct value for the GAPDH gene (Rn 01775763_m1). The variation in expression among samples was calculated by the 2^−ΔΔCt^ method, and the mean delta Ct value for a group of six samples from the control was used for calibration ([@B17]).

Western immunoblotting
----------------------

CSM was frozen in liquid nitrogen and homogenized in lysis buffer (50 mM Tris-HCl, pH 7.4, 1% IGEPAL, 0.5% sodium deoxycholate, 1% SDS). Homogenates were centrifuged at 5,000 *g* for 10 min; the pellet was then discarded, and the supernatant was stored at −80°C. Sixty micrograms of protein were separated by electrophoresis on a 10% or 15% polyacrylamide gel and transferred onto a nitrocellulose membrane. The 15% polyacrylamide gel was used for AM separation. Nonspecific binding sites were blocked with 7% skim milk in Tris-buffered saline solution with Tween 20 for 1 h at 24°C. The membranes were then incubated with the following specific antibodies (Santa Cruz Biotechnology, USA) overnight at 4°C: AM (sc-16496, 1:250 dilution), CRLR (sc-18007, 1:250), RAMP1 (sc-11379, 1:250), RAMP2 (sc-11380, 1:250), and RAMP3 (sc-11381, 1:250). Beta-actin (sc-1616, 1:2000) was used as an internal control. After the membranes were incubated with labeled secondary antibodies, signals were detected by chemiluminescence and visualized by autoradiography.

Immunohistochemistry
--------------------

Paraffin-embedded CSM segments were stained using the avidin-biotinylated peroxidase complex method. Briefly, 4-µm sections (Reichert Jung 2040 microtome, Leica, USA) were cut, deparaffinized with xylene and dehydrated in ethanol. Endogenous peroxidase and biotin were blocked by immersing slides in 3% hydrogen peroxide. The sections were incubated with the following primary antibodies: AM (sc-16496, 1:250) and CRLR (sc-18007, 1:250). The reactions were revealed using 0.2 mg/mL diaminobenzidine solution (10 mg tablets in 50 mL PBS 0.01 M, pH 7.4; D5905; Sigma-Aldrich, USA) and stained by Harris hematoxylin. On each slide, two fields were selected in areas with high concentrations of positive cells or stained cells, using 50× or 1000× magnification. The slides were analyzed using a Leica model DM 5500 B microscope. The images were registered using a Leica digital camera DFC 290 (3MP) attached to the microscope and filed using the Leica QWin software.

Functional studies
------------------

CSM was isolated as described previously ([@B16]). In brief, the penis was harvested by cutting the corporeal body at the level of its attachment to the ischium bone and then immersed in Krebs solution (130 mM NaCl, 4.7 mM KCl, 1.18 mM KH~2~PO~4~, 1.17 mM MgSO~4~.7H~2~O, 1.6 mM CaCl~2~.2H~2~O, 14.9 mM NaHCO~3~, and 5.5 mM glucose). The tunica albuginea was carefully opened from its proximal extremity toward the penile shaft, and the erectile tissue within the corpus cavernosum was surgically dissected free. Strips of CSM (1×1×10 mm) were mounted in a 5-mL organ chamber containing Krebs solution at 37°C and continuously bubbled with a gas mixture of 95% oxygen and 5% carbon dioxide, pH 7.4. One end of each corporal strip was attached to the bottom of the organ bath and the other end was tied to a force transducer (TRI201, Panlab, Spain). The strips were stretched to a resting tension of 3 mN and allowed to equilibrate for 60 min. The responses were recorded on a computer system using Chart Pro 5 (PowerLab, ADInstruments, Australia).

CSM strips were precontracted with phenylephrine (10 µM), and when the contraction reached a plateau, concentration-response curves for AM (10 fM to 30 nM) were obtained by stepwise increase of the agonist concentration. Additions were made as soon as a steady response was obtained from the preceding concentration. For comparison, concentration-response curves for CGRP (1 pM to 0.3 µM) and acetylcholine (1 nM to 1 mM) were also obtained in precontracted CSM strips. Relaxation is reported as the percent change from phenylephrine-contracted levels.

The mechanisms underlying AM-induced relaxation were evaluated by experiments performed in the presence of 100 µM N^G^-nitro-L-arginine-methyl-ester \[L-NAME, a nonselective NO synthase (NOS) inhibitor\], 100 µM 7-nitroindazole \[a selective neuronal NOS (nNOS) inhibitor\], 1 µM 1H-(1,2,4)oxadiazolo\[4,3-a\]quinoxalin-1-one (ODQ, selective guanylyl cyclase inhibitor), 3 µM Rp-8-Br-PET-cGMPS (cGMP-dependent protein kinase inhibitor), 10 µM sildenafil (phosphodiesterase 5 inhibitor), 1 µM wortmannin (phosphatidylinositol 3-kinase inhibitor), 10 µM SC560 (selective cyclooxygenase-1 inhibitor), 1 mM 4-aminopyridine (selective blocker of voltage-dependent K^+^ channels), 1 μM apamin (selective blocker of low-conductance Ca^2+^-activated channels), 3 μM glibenclamide (selective blocker of ATP-sensitive K^+^ channels), 100 μM SQ22536 (adenylate cyclase inhibitor), 1 μM H89 (cAMP-dependent protein kinase inhibitor), 0.01-1 µM AM~22-52~ (AM receptor antagonist), or 0.1 µM CGRP~8-37~ (CGRP receptor antagonist). All drugs were incubated for 30 min. Drug concentrations were selected from the literature ([@B18]-[@B23]). The agonist concentration-response curves were fitted using a nonlinear interactive fitting program (GraphPad Prism 3.0; GraphPad Software Inc., USA). Agonist potencies and maximal responses are reported as pD~2~ (negative logarithm of the molar concentration of agonist producing 50% of the maximal response) and E~max~ (maximum effect elicited by the agonist), respectively.

Nitrate measurements
--------------------

Nitrate (NO~3~ ^−^, a metabolite of NO) levels were measured in supernatants from CSM homogenates. The strips were contracted with 10 µM phenylephrine and then exposed to 30 nM AM or 100 µM L-NAME. Some strips were incubated with 100 µM L-NAME for 30 min prior to the administration of AM. When the maximal relaxation induced by AM was achieved, tissues were frozen in liquid nitrogen. CSM was homogenized in 200 µL PBS buffer, pH 7.4, and centrifuged at 10,000 *g* (10 min, 4°C). The supernatant was ultrafiltered (Amicon Ultra-0.5 mL 10 kDa, Millipore, USA) at 14,000 *g* (15 min, 25°C). A commercially available kit (\#780001, Cayman, USA) was used to measure nitrate levels. Results are reported as μM/mg protein. Protein concentrations were determined with a protein assay reagent (Bio-Rad Laboratories, USA).

6-keto-PGF~1α~ measurements
---------------------------

6-keto-PGF~1α~, a stable hydrolyzed product of unstable prostacyclin (PGI~2~), was measured in CSM homogenates. The strips were contracted with 10 µM phenylephrine and were then exposed to 30 nM AM. When the maximal relaxation induced by AM was achieved, the strips were frozen in liquid nitrogen. CSM was homogenized in EIA buffer (1 M phosphate solution containing 1% BSA, 4 M sodium chloride, 10 mM EDTA and 0.1% sodium azide) and centrifuged at 2000 *g* (15 min, 4°C). The samples (50 µL) were deproteinized by precipitation using 50 µL absolute ethanol kept at 4°C, followed by stirring and then kept for 30 min in a freezer at -20°C. The supernatant was centrifuged at 4000 *g* (10 min, 25°C). Levels of 6-keto-PGF~1α~ were measured using a commercially available kit (Cayman, code 515211). Results are reported as pg/mg protein. Protein concentrations were determined with a protein assay reagent (Bio-Rad Laboratories).

Drugs
-----

ODQ, 7-nitroindazole, SC560, and glibenclamide were prepared as stock solutions in dimethyl sulfoxide (DMSO), whereas the other drugs were dissolved in distilled water. The bath concentration of DMSO did not exceed 0.5%, which was shown to have no effects *per se* on basal tonus of the preparations or on agonist-mediated relaxation.

Statistical analysis
--------------------

Data are reported as means±SE. Statistically significant differences were determined by the Student *t*-test or analysis of variance (ANOVA) followed by the Bonferroni multiple comparison test. P\<0.05 was considered to be statistically significant.

Results
=======

Protein and mRNA expression of AM system components in rat CSM
--------------------------------------------------------------

[Figure 1A](#f01){ref-type="fig"} shows representative immunoblots for AM, CRLR, and RAMP1, -2, and -3 protein expression in rat CSM. The results obtained by qRT-PCR showed that rat CSM expressed mRNA of pre-pro-AM, CRLR, and RAMP1, -2, and -3 ([Figure 1B](#f01){ref-type="fig"}).

![Protein and mRNA expression of AM system components in the rat CSM. *A*, Representative immunoblots for AM, CRLR and RAMP1, -2, -3 protein expression. *B*, mRNA expression of pre-pro-AM, CRLR and RAMP1, -2, -3 in the rat CSM was assessed by qRT-PCR. The results are reported as the expression of the individual mRNAs with normalization to the housekeeping gene GAPDH by using the Ct method. Data are reported as means±SE of n=5 to 7 CSM. AM: adrenomedullin; CSM: cavernosal smooth muscle; CRLR: calcitonin receptor-like receptor; RAMP: receptor activity-modifying protein.](1414-431X-bjmbr-47-10-00876-gf001){#f01}

### Expression and localization of AM and CRLR in rat CSM

Immunohistochemical studies revealed staining for AM and CRLR in rat cavernous tissue. Nuclear staining for both AM and CRLR were detected diffusely in all constituents of the cavernous tissue including connective tissue, in the endothelium lining vascular spaces, and in smooth muscle ([Figure 2](#f02){ref-type="fig"}).

![Representative immunohistochemical photomicrographs of adrenomedullin (AM) and calcitonin receptor-like receptor (CRLR) in rat cavernosal smooth muscle sections. AM (*A*) and CRLR (*B*) nuclear staining (arrows on the images in detail) were detected diffusely in all constituents of the cavernous tissue (CT): connective tissue, endothelium lining the vascular spaces and in smooth muscle. A: tunica albuginea; C: corpora cavernosa; E: spongy body; VS: vascular spaces; U: urethra. Magnification 50× and 1000× (inset).](1414-431X-bjmbr-47-10-00876-gf002){#f02}

### Mechanisms underlying the relaxant effect induced by AM in isolated CSM strips

AM relaxed rat CSM strips in a concentration-dependent manner (E~max~: 53.9±2.5%; pD~2~: 10.6±0.2, n=6). Similarly, CGRP (E~max~: 52.5±6.9%; pD~2~: 10.0±0.2, n=6) and acetylcholine (E~max~: 54.7±2.3%; pD~2~: 6.8±0.2, n=5) relaxed CSM strips ([Figure 3](#f03){ref-type="fig"}). The maximal relaxation induced by the agonists was of similar magnitude. However, AM and CGRP were more potent than acetylcholine at inducing CSM relaxation (P\<0.05, ANOVA).

![Concentration-response curves for AM, CGRP, and acetylcholine obtained in isolated rat cavernosal smooth muscle strips. The curves were obtained in CSM pre-contracted with phenylephrine (10 µM). Data are reported as means±SE of 5 to 6 independent preparations. AM: adrenomedullin; CGRP: calcitonin gene-related peptide.](1414-431X-bjmbr-47-10-00876-gf003){#f03}

In order to verify the mechanisms underlying AM-induced relaxation, CSM strips were exposed to a variety of drugs. AM~22-52~, a selective antagonist for AM receptors, reduced the maximal relaxation induced by AM in isolated rat CSM. The relaxation induced by AM (E~max~: 53.9±2.5%; pD~2~: 10.9±0.3, n=6) was significantly reduced (P\<0.05, ANOVA) in the presence of AM~22-52~ at concentrations of 0.1 µM (E~max~: 38.3±3.9%; pD~2~: 10.8±0.4, n=6), 0.3 µM (E~max~: 31.9±1.9%; pD~2~: 10.8±0.2, n=6) and 1 µM (E~max~: 20.4±0.9%; pD~2~: 10.6±0.2, n=6) ([Figure 4](#f04){ref-type="fig"}). At the concentration of 0.01 µM, AM~22-52~ did not affect AM-induced relaxation (E~max~: 43.8±1.5%; pD~2~: 10.5±0.1, n=6). Similarly, CGRP~8-37~ (E~max~: 44.1±1.8%; pD~2~: 10.6±0.3, n=6) did not alter the relaxation induced by AM ([Figure 4](#f04){ref-type="fig"}). Neither H89 (E~max~: 49.7±7.7%; pD~2~: 11.1±0.4, n=5) nor SQ22536 (E~max~: 51.6±1.8%; pD~2~: 11.4±0.2, n=5) altered AM-induced relaxation ([Figure 5](#f05){ref-type="fig"}). L-NAME, ODQ, Rp-8-Br-PET-cGMPS, and SC560 reduced AM-induced relaxation to a similar extent ([Figure 6](#f06){ref-type="fig"}, [Table 1](#t01){ref-type="table"}). The combination of L-NAME and SC560 showed further suppression of AM relaxation than that observed with either L-NAME or SC560 alone. However, even when combined, these compounds were not able to abolish AM-induced relaxation. Sildenafil induced a leftward displacement in the concentration-response curve for AM. Conversely, 7-nitroindazole and wortmannin did not alter the relaxation induced by AM ([Figure 6](#f06){ref-type="fig"}, [Table 1](#t01){ref-type="table"}). 4-Aminopyridine, but not apamin or glibenclamide, reduced the relaxation induced by AM in rat CSM ([Figure 7](#f07){ref-type="fig"}, [Table 1](#t01){ref-type="table"}).

![Concentration-response curves for AM obtained in rat cavernosal smooth muscle strips in the absence or presence of 0.01-1 µM AM~22-52~ and 0.1 µM CGRP~8-37~. Data are reported as means±SE of 5 to 6 independent preparations. AM: adrenomedullin; CGRP: calcitonin gene-related peptide.](1414-431X-bjmbr-47-10-00876-gf004){#f04}

![Relaxation responses induced by adrenomedullin (AM) on rat cavernosal smooth muscle strips pre-contracted with phenylephrine. The concentration-response curves were obtained in the absence (control) or after incubation for 30 min with 100 μM SQ22536 (*top*) or 1 μM H89 (*bottom*). Data are reported as means±SE of 5 independent preparations.](1414-431X-bjmbr-47-10-00876-gf005){#f05}

![Relaxation responses induced by adrenomedullin (AM) on rat cavernosal smooth muscle strips pre-contracted with phenylephrine. The concentration-response curves were obtained in the absence (control) or after incubation for 30 min with the following drugs: 100 µM L-NAME, 100 µM 7-nitroindazole, 1 µM ODQ, 3 µM Rp-8-Br-PET-cGMPS, 10 µM sildenafil, 1 µM wortmannin, 10 µM SC560, or the combination of L-NAME and SC560. Data are reported as means±SE of 5 to 6 independent preparations.](1414-431X-bjmbr-47-10-00876-gf006){#f06}

![Relaxation responses induced by adrenomedullin (AM) on rat cavernosal smooth muscle strips pre-contracted with phenylephrine. The concentration-response curves were obtained in the absence (control) or after incubation for 30 min with 3 µM glibenclamide, 1 µM apamin, or 1 mM 4-aminopyridine. Data are reported as means±SE of 5 to 6 independent preparations.](1414-431X-bjmbr-47-10-00876-gf007){#f07}

Nitrate and 6-keto-PGF~1α~ measurements
---------------------------------------

AM significantly increased 6-keto-PGF~1α~ (a stable product of PGI~2~) in rat CSM compared with tissues that were not stimulated with the peptide ([Figure 8A](#f08){ref-type="fig"}). AM significantly increased nitrate generation in rat CSM compared with tissues that were not stimulated with the peptide ([Figure 8B](#f08){ref-type="fig"}). AM-induced nitrate generation was significantly inhibited by L-NAME, which had no effect *per se* on basal nitrate levels.

![6-keto-PGF~1α~ and nitrate levels in rat cavernosal smooth muscle strips stimulated with adrenomedullin (AM). Data are reported as means±SE of 5 to 6 independent preparations. \*P\<0.05, compared to basal (Student *t*-test); ^\#^P\<0.05, compared to basal, L-NAME, and AM+L-NAME (ANOVA followed by the Bonferroni multiple comparison test).](1414-431X-bjmbr-47-10-00876-gf008){#f08}

Discussion
==========

In the present study, protein and mRNA expression of AM, CRLR, and RAMP1, -2, and -3 were detected in rat CSM. Immunohistochemical assays showed that AM and CRLR are expressed in the cavernous tissue. AM acts as a circulating hormone and locally in an autocrine/paracrine fashion. Because AM is expressed in rat CSM, it may play a role in the autocrine/paracrine regulation of penile erection due to its vasodilator action. AM is considered an important regulatory peptide that helps to regulate cardiovascular homeostasis. AM levels in cardiovascular tissues are elevated to compensate for changes induced by cardiovascular diseases such as atherosclerosis and hypertension ([@B24]). Thus, increased AM expression in CSM could exert a protective action against ED. In fact, it has been suggested that combination therapy using PGE~1~ and proerection agents such as AM may be beneficial in the treatment of ED ([@B25]).

A pharmacological characterization of the mechanisms mediating the relaxant effect of AM in rat CSM was attempted with functional assays, using standard muscle bath procedures. AM induced CSM relaxation in a concentration-dependent manner. AM was similar in potency to CGRP, and both were more potent than acetylcholine, which is in accordance with previous findings in rat aorta ([@B26]), rat mesenteric arterial bed ([@B27]), and cat CSM ([@B06]). Relaxation induced by AM has been previously described in isolated rabbit CSM in a concentration range different from that employed in the present study ([@B11]). A possible explanation for such discrepancy is that the mechanism by which AM induces vasorelaxation or erection varies with species, vascular bed studied, and experimental procedure employed ([@B05]-[@B07],[@B11],[@B28]).

The AM receptor is composed of the CRLR and specific RAMP ([@B09],[@B10]). RAMPs are a class of type I transmembrane proteins that interact with and modulate the activities of G protein-coupled receptors. Cell surface RAMP2-CRLR and RAMP3-CRLR complexes are AM receptors, while the RAMP1-CRLR complex forms the CGRP receptor ([@B09],[@B10]). RAMP interaction with its associated receptor can lead to three potential consequences: trafficking of receptor protein from an intracellular compartment to the cell surface, alteration in the terminal glycosylation of the receptor, and alteration of receptor phenotype, presumably through a direct or indirect effect on the ligand-binding site ([@B29]). Although the antagonist AM~22-52~ has been shown to selectively inhibit AM receptors, CGRP~8-37~ is a CGRP receptor antagonist that has been shown to be able to block some, but not all, of the actions of AM in the vasculature ([@B30]). This observation indicates that the vasorelaxation induced by AM may occur due to its interaction with both AM or CGRP receptors. The present findings show that AM-induced CSM relaxation was attenuated by AM~22-52~, but not CGRP~8-37~. Our study provides the first functional evidence that relaxation induced by AM in rat CSM is solely mediated by AM receptors.

Activation of adenylate cyclase with consequent increase in cAMP and cAMP-dependent protein kinase activation has been implicated in the vascular relaxation induced by AM ([@B31],[@B32]). In our study, neither SQ22536 nor H89 altered AM-induced relaxation, which is not consistent with the participation of adenylate cyclase and protein kinase in this response.

In some vascular tissues, AM induces relaxation via production of NO, with consequent increases in cGMP levels ([@B33],[@B34]). NO is formed from L-arginine by the catalytic action of the enzyme NOS. The latter has three isoforms: nNOS (or NOS type I), inducible NOS (or NOS type II), and endothelial NOS (eNOS or NOS type III). nNOS and eNOS are the main isoforms involved in penile erection and are present in the nerves and endothelium of the penis, respectively ([@B35]). Our data show that L-NAME partially, but significantly, reduced AM-mediated relaxation. In addition, AM increased nitrate levels in rat CSM, and this response was inhibited by L-NAME, further implicating NOS in this process. Taken together, these results show that activation of NOS with consequent NO generation play a role in AM-mediated relaxation. 7-Nitroindazole, a selective nNOS inhibitor, had no effect on AM-induced relaxation, suggesting that this NOS isoform could not account for the AM-mediated relaxation in rat CSM. The selective inhibitor of guanylyl cyclase enzyme, ODQ, reduced the relaxant action of AM, confirming the involvement of the NO-cGMP pathway in this response as previously observed in cat and rat CSM ([@B05]-[@B07]). cGMP-stimulated protein kinase (PKG) acts downstream to reduce Ca^2+^ concentration and/or the sensitivity of the contractile proteins to Ca^2+^, thus leading to smooth muscle relaxation. Our findings show that PKG activation plays a role in AM-induced relaxation because Rp-8-Br-PET-cGMPS reduced this response. Phosphodiesterase type 5 (PDE5) is widely expressed in CSM, where it catalyzes cGMP hydrolysis ([@B36]). Sildenafil, a PDE5 inhibitor, induced a leftward displacement of the concentration-response curves for AM, further suggesting that PDE5 negatively modulates the relaxation induced by AM.

AM has also been shown to elicit phosphatidylinositol 3-kinase (PI3K) activation and Akt phosphorylation, resulting in the stimulation of eNOS ([@B37]). Our findings with wortmannin discard the participation of the PI3K/Akt pathway on AM-induced relaxation. It is important to note that blockade of the NO-cGMP pathway only partially attenuated the relaxant response induced by AM, indicating that mediators unrelated to the production of NO also participate in this response. In fact, we observed that the relaxation evoked by AM was partially blunted by SC560, an inhibitor of cyclooxygenase-1, suggesting the involvement of vasodilator prostanoids in the relaxing effect of AM. Additionally, AM increased 6-keto-PGF~1α~, a stable product of PGI~2~. These results agree with a previous finding showing the participation of prostanoids in AM-induced relaxation in porcine ciliary arteries ([@B38]). When L-NAME and SC560 were simultaneously added to the organ bath, an additional inhibitory effect on AM-induced relaxation was observed, indicating that both NO and vasodilator prostanoids participate in this response.

Activation of K^+^ channels is an important mechanism in vascular smooth muscle hyperpolarization and relaxation, and cGMP can modulate the activity of K^+^ channels to elicit vasodilatation. A role for K^+^ channels in AM-mediated relaxation has already been described for vasculature ([@B27],[@B38]). We found that 4-aminopyridine, but not glibenclamide or apamin, reduced AM-induced relaxation, indicating that the activation of voltage-sensitive K^+^ channels plays a role in such responses.

The major new finding of the present study is that AM receptors mediate CSM relaxation via the NO-cGMP pathway, vasodilator prostanoids (probably PGI~2~), and the opening of K^+^ channels. Studies of the expression and function of AM receptors in CSM may provide valuable information on the contribution of AM to CSM tone, since this tissue is a useful model for the study of penile erectile responses and ED.
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